Notice of Funding Opportunity for Rare Disease Therapeutic Development
National Institutes of Health
Description
This grant opportunity supports research studies in rare diseases using preclinical models to show the potential of new treatments. It provides funding for studies on how the drugs work and how they are processed in the body, with the aim of advancing projects to attract more investment for further drug development or clinical trials.
This NOFO aims to support efficacy studies in rare disease preclinical models to demonstrate the potential of therapeutic agents for further development. It includes support for pharmacodynamic and pharmacokinetic studies. The goal is to advance projects to attract further investment for IND app…
Source
Grant ID
RFA-TR-25-002
Agency
National Institutes of Health
Subcategory/Subagency
National Center for Advancing Translational Sciences
Key Dates
Opportunity Released
December 6, 2024
Eligibility
The following categories of applicants are invited to apply:
- U.S. Territories or Possessions
- Independent School Districts
- Public Housing Authorities/Indian Housing Authorities
- Native American Tribal Organizations (other than Federally recognized tribal governments)
- Faith-based or Community-based Organizations
- Regional Organizations
- Higher Education Institutions (Public/State Controlled Institutions of Higher Education)
- Higher Education Institutions (Private Institutions of Higher Education)
- Nonprofits Other Than Institutions of Higher Education (with 501(c)(3) IRS Status)
- Nonprofits Other Than Institutions of Higher Education (without 501(c)(3) IRS Status)
- For-Profit Organizations (Small Businesses)
- For-Profit Organizations (Other than Small Businesses)
- Local Governments
- State Governments
- County Governments
- City or Township Governments
- Special District Governments
- Indian/Native American Tribal Governments (Federally Recognized)
- Indian/Native American Tribal Governments (Other than Federally Recognized)
- Federal Government
- Eligible Agencies of the Federal Government
Similar opportunities
- Accelerating Innovative Drug and Device Therapies Translation from Discovery to Early Human Studies
National Institutes of Health
- Ultra-Rare Gene-Based Therapy (URGenT) Network
National Institutes of Health
- Notice of Funding Opportunity for Pre-clinical and Early Stage Clinical Development of Drug Candidates for Alzheimer's Disease
National Institutes of Health
- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01)
Food and Drug Administration
- Efficient and Innovative Natural History Studies for Rare Diseases
Department of Health and Human Services